#graph therapeutics Tech News.
2 stories in the last 7 days
The latest graph therapeutics news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks graph therapeutics across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Graph Therapeutics, founded by Allcyte co-founder Gregory Vladimer, raised $5M from Daphni to develop its own medicines. The Vienna-based startup targets inflammation and immunology diseases by testing drugs on living patient cells and applying machine learning. Total funding now exceeds $10M.
Graph Therapeutics secured a $5 million investment led by Daphni, bringing total funding to over $10 million. The techbio company uses a lab-in-the-loop AI platform to decode immune dysfunction from patient tissue. The capital will advance its internal pipeline for inflammatory and immune-mediated diseases.
Summaries by ByteBrief